SEC Form 5 · accession 0001225208-18-002817
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W Bird
Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 13, 2018 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 1, 2017 | G | 0 | $0.00 | D | 36,602 | I | By Ltd Partnership (NEST) |
| Common Stock | holding | — | — | — | 6,000 | D | ||
| Common StockF3 | holding | — | — | — | 921,610 | I | By Ltd Partnership (SHV) | |
| Common StockF4 | holding | — | — | — | 59,053 | I | By Trust (Trustees) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.
- F2Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership of these shares except as to the reporting person's pecuniary interest therein.
- F3Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
- F4Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.